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Key Points
Question
Do patients with moderate to severe obstructive sleep apnea have thinner calvaria and skull bases compared
with those without obstructive sleep apnea?
Findings
In this cohort study, obstructive sleep apnea was independently associated with calvarial and skull base
thinning compared with obese, age-matched patients without obstructive sleep apnea. The patients with
obstructive sleep apnea had a higher rate of tegmen dehiscence than those without obstructive sleep apnea.
Meaning
Obstructive sleep apnea may mechanistically contribute to the development of disorders related to skull
thinning, such as spontaneous cerebrospinal fluid leaks.
Abstract
Importance
Spontaneous cerebrospinal fluid leaks (sCSF-L) of the temporal bone are associated with obesity, calvarial
thinning, and obstructive sleep apnea (OSA), and the incidence has doubled in the past decade. It is
currently unknown if OSA is independently associated with skull thinning.
Objective
To determine if patients with OSA have thinner skulls than patients without OSA.
Design, Setting, and Participants
A retrospective cohort study of patients who underwent a level 1 polysomnogram (PSG) and also had high-
resolution computed tomographic (CT) imaging of the head from January 2010 to March 2017 at Indiana
University was carried out. Patients with moderate to severe OSA (apnea-hypopnea index [AHI]≥25/h) and
without OSA (AHI<5/h) were matched for age and body mass index (BMI, calculated as weight in
kilograms divided by height in meters squared).
Interventions
Measurement of calvarial thickness, extracranial zygoma thickness, skull base height and tegmen
dehiscence (>4 mm) when blinded to OSA status.
Main Outcomes and Measures
Primary outcomes were calvarial, skull base, and zygoma thickness differences between patients with OSA
vs those without OSA.
Results
A total of 22 933 patients had a PSG and 1012 also had head CT imaging. Of the 1012 patients with both
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PSG and CT, the mean (SD) age was 50.8 (16.2) years and 624 (61.7%) were women. Those patients with
moderate to severe OSA (56) and without OSA (58) were matched for mean (SD) age (50.3 [6.5] vs 49.8
[6.1] years]) and BMI (37.4 [8.1] vs 38.6 [6.8]). Patients with OSA had thinner mean (SD) calvaria (2.73
[0.67] vs 2.47 [0.52] mm; difference, −0.26 mm; 95% CI, −0.49 to −0.04; Cohen d, 0.44) and thinner skull
bases (5.03 [1.40] vs 4.32 [1.28] mm; difference, −0.71; 95% CI, −1.23 to −0.19; Cohen d, 0.53). The mean
(SD) extracranial zygoma thickness was the same (4.92 [0.87] vs 4.84 [0.84] mm; difference, −0.07 mm;
95% CI, −0.39 to 0.24). The tegmen mastoideum was dehiscent in nearly twice as many patients with OSA
as those without (37% vs 20%; difference, 17%; 95% CI, 0.4-32).
Conclusions and Relevance
Obstructive sleep apnea was independently associated with intracranial bone (calvaria and skull base)
thinning and not with extracranial (zygoma) thinning. These findings support a possible role of OSA in the
pathophysiologic development of sCSF-L.
Introduction
Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder in adults.  The
estimated prevalence of moderate-to-severe OSA in the United States is 10% to 17% in men and 3% to 9%
in women.  The prevalence of OSA varies based on the defining criteria used and the population being
studied.  Obesity is the most common modifiable risk factor for OSA.  Owing to rising obesity rates in the
United States, the prevalence of OSA has risen by 14% to 55% over the past 2 decades.  Polysomnography
is the gold standard for diagnosing OSA. Obstructive sleep apnea is linked to multiple comorbid
conditions,  including cardiovascular disease,  chronic fatigue,  stroke,  and increased all-cause
mortality.
Spontaneous cerebrospinal fluid leak (sCSF-L) occurs when there is a defect in the bone and dura of the
skull base overlying pneumatized spaces. This process takes place in the absence of other causes such as
tumor, trauma, or surgery.  Spontaneous cerebrospinal fluid leak is associated with obesity, female sex, and
middle age.  Consistent with the rise in obesity in the United States, the rates of sCSF-L have
more than doubled in the past decade.
The exact mechanism of sCSF-L is still not well understood. It is known that patients with sCSF-L have
isolated cranial bone defects of the skull base and global calvarial thinning without thinning of extracranial
bones (zygoma).  This suggests an intracranial process leads to skull thinning and the development of
sCSF-L.  Elevated intracranial pressure (ICP) on a constant or transient basis has been postulated to lead to
skull thinning over time.  Elevated ICP has been documented in some (approximately 36%) but not
all patients with sCSF-L.  In addition, OSA is associated with transient spikes in ICP during apnea
episodes  and the prevalence of OSA is 83% in patients with sCSF-L.
Our study aimed to determine if OSA is independently associated with skull thinning by investigating the
radiologic skull base and calvaria findings in non–sCSF-L patients with and without OSA based on formal
PSG testing. To our knowledge, no studies have established a connection between OSA and skull thinning.
Methods
Patient Selection
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This study was approved by the institutional review board at Indiana University School of Medicine in
Indianapolis (protocol 1702192365). Informed consent was waived by the board given the absence of
patient-identifying information. The sleep disorders center database at Indiana University was queried for all
patients who underwent a formal diagnostic polysomnogram (PSG) from January 1, 2010, to March 31,
2017 (22 933 unique patients). Patients who also had high-resolution (≤1-mm axial and coronal sections) CT
of the head (inner ear, internal auditory canal, maxillofacial area/sinus, orbit, paranasal sinuses, petrous
bone, and CT temporal bone) from January 1, 2001, to April 31, 2017, were evaluated (1012 patients) (
Figure 1).
Patients were divided into 2 groups based on apnea-hypopnea index (AHI): a non-OSA group (AHI<5), and
a moderate to severe OSA group (AHI≥25). We chose this OSA group to obtain sufficient numbers of
patients with the most severe degree of OSA, as we hypothesized that those with the highest AHI would
have the largest possible effect on skull thinning compared with those without OSA. To adequately power
the study we chose matched cohorts with AHI≥25. Patients with AHI of 5 to 24 or age younger than 18
years were excluded. In the non-OSA cohort, patients with a body mass index (BMI, calculated as weight in
kilograms divided by height in meters squared) less than 25 and aged younger than 40 years were excluded
to better match age and BMI between the groups. One patient with cranio-osteogenic pathology was
excluded and 2 patients with sCSF-L were excluded (1 OSA and 1 non-OSA). These patients with sCSF-L,
along with other patients with sCSF-L identified earlier in our patient selection process, were placed in a
subgroup of their own for further analysis. For all patients, medical records were searched for medical
history of smoking, diabetes, hypertension, and osteopenia to help match patients based on these
comorbidities, which may be associated with bone thinning and obesity.  In this initial patient selection
process, our criteria yielded 82 patients in the non-OSA cohort and 92 patients in the OSA cohort (Figure 1
).
Race data were obtained and assigned from the electronic medical record as documented during previous
patient hospital visits; thus, the investigators had no role in classifying race. Owing to a relatively low
number of black patients available for measurements and an unequal proportion of black patients in each
subgroup, we could not isolate a well-matched group of black patients to adequately power a group
comparison between OSA and non-OSA patients. As a result, black patients were excluded.
Our power calculation was based on our preliminary findings. We anticipated a mean (SD) difference in
calvarial thickness of 0.3 (0.55) mm between patients with OSA vs those without OSA. The estimated
sample size needed to achieve a power of 0.8 with an α of 0.05 for this comparison was 53 measurements
per group. Accordingly, an appropriate number of white patients matched by age, sex, hemoglobin A1c
levels, and BMI were then obtained for subgroup analysis (28 patients with OSA and 29 in patients without
OSA).
Finally, we also isolated a group of sCSF-L patients for further comparison. These were patients from
Indiana University who had presented for repair of sCSF-L in the past 3 years. These patients had PSG
studies available and also had high-resolution CT scans of the head, and we aimed to compare findings
between our OSA, non-OSA, and sCSF-L groups.
Radiologic Analysis and Measurements
After our patient groups were determined, CT scans were obtained, deidentified, and randomized for
analysis. Measurements were performed when blinded to OSA status. Measurements were performed using
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3D Slicer (version 4.6.2, http://www.slicer.org) an open source, NIH-funded image analysis tool. We
developed an accurate and consistent method of measuring calvarial and zygoma thickness (eMethods in the
Supplement) (Figure 2A and B). Coronal imaging was used to determine the skull base thickness (height of
the internal auditory canal) and the rate of tegmen dehiscence (eMethods in the Supplement). Zygoma
thickness was used as an internal imaging control because the extracranial zygoma is not subject to
intracranial forces. Measurements were performed and reported bilaterally, with n = number of
measurements, yielding 2 measurements for each patient. A small number of CT scans did not extend
posterior enough to adequately measure skull base height. Thus, the n for Figure 2 and Figure 3 differ
slightly.
Statistical Analysis
Data was aggregated with Excel software (2013, Microsoft Corp). Statistical analysis was performed to
determine the existence of significant differences between the measurements and demographic patient data
obtained. All data analyses were carried out using SPSS statistical software (version 24, IBM Corp). Two-
tailed independent samples t tests were applied. For all tests, 95% confidence intervals (CIs) were used to
inform statistical and clinical significance. Cohen d was used as a measure of effect size where indicated.
Based on Cohen d, we consider d = 0.2 to be a small effect, d = 0.5 to be moderate effect, and d≥0.8 to be
large effect.
Results
Of the 23 916 patients first reviewed, 174 patients were initially included in this study based on the
exclusion and inclusion criteria applied (Figure 1). Ninety-two patients were diagnosed with moderate to
severe OSA and 82 did not have OSA based on PSG testing. These patients underwent calvarial and zygoma
thickness measurements using 3D Slicer (Figure 2A and B). In this initial cohort of patients, our preliminary
measurements suggested a difference in skull and skull-base thickness based on race, but owing to low
patient numbers in the black subgroup, no definitive conclusions could be drawn. As a result, black patients
were excluded from further analysis. As noted in the Methods section, we then sought to isolate a clinically
relevant and well-matched cohort with enough patients to adequately power a group comparison between
patients with OSA and those without OSA. Patients between the ages of 40 and 60 years were selected
because they were the most well-matched, were the most common ages in the cohort, and were also
clinically relevant given the high prevalence of sCSF-L in middle-aged patients.
Our cohort of patients aged 40 to 60 years allowed for a total of 58 and 56 measurements in the non-OSA
and OSA groups, respectively. The mean timeframe between PSG and CT imaging was less than 2 years
and did not differ between groups (OSA, 21.7 months vs non-OSA, 20.9 months). The non-OSA and OSA
groups were matched for mean (SD) age (49.8 [6.1] years vs 50.3 [6.5] years), average BMI (38.6 [6.8] vs
37.4 [8.1]), and average hemoglobin A1c levels (7.09% [2.22%] vs 7.03% [2.16%]) (Table). Sex did not
have an effect on mean calvarial or zygoma thickness in this cohort. Compared with those without OSA,
patients with OSA had significantly thinner calvaria (mean [SD], 2.73 [0.67] vs 2.47 [0.52] mm; difference,
−0.26 mm; 95% CI, −0.49 to −0.04; Cohen d, 0.44) (Table) (Figure 2C). As an extracranial control, the
zygoma thickness was not significantly different between the 2 groups (mean [SD], 4.92 [0.87] vs 4.85
[0.84] mm; difference, −0.07 mm; 95% CI, −0.39 to 0.24) (Table) (Figure 2D).
Next, we sought to compare our findings with a cohort of temporal bone sCSF-L patients we had identified
during our patient selection process, a cohort that is known to have tegmen dehiscence and skull thinning.
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Nine patients with sCSF-L (18 measurements) were white, between the ages of 40 and 60 years, with a
statistically similar mean (SD) age of 52 (5.2) years, and a mean (SD) BMI of 35.1 (5.9). Patients with
sCSF-L had significantly thinner calvaria than patients without OSA, with a 17.9% difference in thickness
(mean [SD], 2.73 [0.67] vs 2.24 [0.64] mm; difference, −0.49; 95% CI, −0.97 to −0.01; Cohen d = 0.74) (
Figure 2C). Calvarial thickness was not significantly different between patients with OSA and patients with
sCSF-L (mean [SD], 2.47 [0.52] vs 2.24 [0.64] mm; difference, −0.23; 95% CI, −0.62 to 0.15; Cohen,
d = 0.39) (Figure 2C). The extracranial zygoma thickness was not statistically significantly different
between the 3 groups (non-OSA: 4.92 [0.87] vs OSA: 4.85 [0.84] vs sCSF: 4.66 [0.89] mm) (Figure 2D).
In addition to the calvaria, the skull base was also thinner in patients with OSA. Among patients aged 40 to
60 years, those with OSA had significantly thinner mean (SD) skull bases than those without OSA (5.03
[1.40] vs 4.32 [1.28] mm; difference, −0.71; 95% CI, −1.23 to −0.19; Cohen d = 0.53) (Figure 3A-C). The
tegmen mastoideum was dehiscent in nearly twice as many of the patients with OSA as those without OSA
(37% vs 20%; difference, 17%; 95% CI, 0.4%-32%) (Figure 3D-F).
Discussion
In obese middle-aged white patients, moderate to severe OSA has been independently associated with
calvarial and skull base thinning. The CIs for OSA vs non-OSA calvaria and skull base differences are both
relatively narrow, suggesting precision in the measurements. The Cohen d values for both calvarium (0.44)
and skull base (0.53) demonstrate a moderate effect size. The upper limit of the 95% CI for skull base height
was 1.23 mm, a clinically meaningful finding because skull base erosion and thinning to a magnitude of 1
mm may be sufficient to cause a sCSF-L in inherently thin portions of the skull base.
The strength of this study includes the nonbiased approach to evaluate a cohort of patients with objective in-
laboratory PSG testing and the use of a highly accurate quantification method for skull measurement. This
study suggests that, with further research, we may develop the ability to risk stratify patients for risk of OSA
based on head imaging, and this has broad implications for the tens of thousands of patients who have head
CT imaging every year.
Patients with sCSF-L by definition have bony defects in the skull base and are typically obese (mean BMI,
38), female (72%), and middle-aged (45-65 years).  An isolated intracranial process is hypothesized to
mechanistically cause sCSF-L because these patients have global calvarial thinning with no thinning in
extracranial bones.  Chronically elevated or transient spikes in ICP theoretically could result in calvarial
and skull base thinning.
Some studies have proposed that this increased ICP may be caused by obesity,  as a positive linear
relationship has been shown between CSF pressure and BMI.  However, skull thinning was not seen in a
control group of obese patients without sCSF-L.  These data suggest that other obesity-related factors are
implicated in calvarial and skull base thinning.  Importantly, elevated ICP has only been observed in 10%
to 36% of patients with sCSF-L.  In addition, OSA, which is strongly associated with obesity,  has
been shown to cause transient elevations in ICP during apneic episodes.  A recent prospective study
found that the prevalence of OSA among patients with sCSF-L is 83%.
We investigated a cohort of patients who were obese, yet did not have sCSF-L, and discovered that patients
with moderate to severe OSA have thinning of the squamous portion of the temporal bone and skull base
compared with non-OSA patients, a relationship independent of age, BMI, sex, and multiple comorbidities.
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We also found that patients with sCSF-L had nearly 20% thinner calvaria than those without OSA, similar
to previous studies showing a mean 22% thinning of the skull in patients with sCSF-L.  We used the
thickness of the squamous temporal bone as a surrogate for global calvarial thickness because it is not
feasible to measure the entire calvarium.  Our data suggest that an intracranial process in patients with
moderate to severe OSA leads to skull and skull base thinning.
Overall, our study suggests that OSA may independently increase the risk of developing sCSF-L. We
propose that OSA, when untreated for prolonged periods of time, plays a role in progressive calvarial and
skull base thinning, and this continuous thinning may eventually be sufficient to cause CSF fistulae. Our
data show that patients without OSA, patients with OSA, and patients with sCSF-L fall on a continuum of
skull thinning (Figure 2C and D), while their zygoma thickness measurements are not statistically
significantly different (Figure 2C and D), supporting our theory of progressive calvarial thinning. These
findings add to the discussion regarding the association of obesity and OSA with sCSF-L.
Limitations
A potential limitation of this study is the small sample size in our final groups relative to our initial large
number of patients. However, we would argue that this relatively small sample size was inevitable; we
aimed to control for numerous variables to investigate the independent effect of OSA on calvarial and
zygoma thickness, and to do so required strict criteria for patient inclusion. Thus, our study required us to
begin with a very large number of patients to maintain adequate power during our exclusion steps, and we
always intended to isolate a very select cohort of patients. In future studies, increasing our study sample size
would increase the precision of the CIs.
Also, our study is limited by the exclusion of black patients. However, we believe that this step was
necessary because we found a possible effect of race on calvarial and zygoma thickness in preliminary
measurements, and we were not able to isolate a well-matched cohort of black patients with adequate power
for further analysis. We feel that our study is as representative as possible and clinically relevant, given that
our subgroup of white patients aged 40 to 60 years parallels the demographic known to be at highest risk of
sCSF-L.  Of note, our need to stratify our data by race highlights the need for future studies to delineate
race when looking at differences in skull thickness between various groups. Future studies investigating the
prevalence of sCSF-L in white and black populations would be valuable and should aim to include an
adequate number of black patients to allow meaningful conclusions to be drawn about the impact of race on
skull measurements in patients with OSA.
Our study also included different types of high-resolution CT scans with small inherent differences.
However, we accounted for this by using a correction factor (eMethods in the Supplement) to augment the
CT internal auditory canal (IAC) measurements, and this likely strengthened our data. By augmenting the
CT IAC measurements, the predominant study ordered for patients with sCSF-L, we were able to
compensate for any intrinsic aspect of the scan results that could yield a lower measurement in this
subgroup. Our data highlights a need for future studies investigating skull thickness to account for intrinsic
differences between CT scan results.
Another potential limitation of our study is our inability to account for other causes of skull thinning that are
yet to be discovered. We controlled for all known variables including age, race, sex, BMI, and
comorbidities, but some variables were not possible to account for. For example, it was not possible to
measure ICP in patients owing to the retrospective nature of our study and the reluctance of patients to
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prospectively sign up for nonindicated lumbar punctures. Thus, we were not able to delineate the
relationship between OSA and increased ICP in these study patients, and so we deferred to the available
literature, which suggests that OSA causes transient spikes in ICP during sleep.  The development of
sCSF-L is likely a multifactorial process and we believe that OSA is an important factor among others.
Conclusions
By analyzing the results of CT scans of patients with and without OSA, we have found a significant
relationship between OSA and calvarial and skull base thinning. Based on our results, OSA likely plays a
role in the pathophysiology of skull base thinning and may contribute to the development of sCSF-L. Future
studies are needed to identify the mechanism of how OSA may lead to skull thinning and how this may
increase the risk of sCSF-L. Patients with skull thinning on CT imaging may be at increased risk of OSA
and those patients should be considered for OSA screening using tools such as the STOP-Bang
questionnaire. Future studies may reveal the utility of radiologic skull measurements as predictors of OSA.
Future studies may also reveal other factors contributing to the development of sCSF-L.
Notes
Supplement.
eMethods.
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Patient Selection Flowchart
Abbreviations: AHI, apnea-hypopnea index; BMI, body mass index (calculated as weight in kilograms divided by height in
meters squared); OSA, obstructive sleep apnea; PSG, polysomnogram.
Patients were identified by first searching the Sleep Disorders Database for all patients who underwent a PSG since 2010.
There were 1012 patients with a PSG and a high-resolution computed tomographic (CT) scan of the head available for
measurements. From these patients, 2 cohorts were isolated: A non-OSA cohort consisting of 82 patients, and a severe OSA
cohort consisting of 92 patients.
Calculated as weight in kilograms divided by height in meters squared.
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Calvarial and Zygoma Measurements in Non-OSA, OSA, and sCSF-L Patients
Abbreviations: NS, not significant; OSA obstructive sleep apnea; sCSF, spontaneous cerebrospinal fluid leak. A,
Measurements were taken in the coronal plane of a 15-mm (height) segment of the thinnest portion of the squamous
temporal bone. Segments were highlighted bilaterally, starting at the level of the foramen rotundum anteriorly and
extending posteriorly to the level of the upper extent of the superior semicircular canal. Volume was calculated using 3D
Slicer’s volumetric analysis tool (version 4.6.2, http://www.slicer.org). B, A 3-Dimensional reconstruction illustrating the
highlighted calvarial segment. C, Patients with OSA and patients with sCSF-L had statistically significantly thinner skulls
than patients without OSA. Skull thickness was not statistically significantly different between patients with OSA and those
with sCSF-L. D, There were no statistically significant differences in zygoma thickness between non-OSA, OSA, and
sCSF-L patients. Dashed line indicates that patients with sCSF-L were not part of the original database search.
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Skull Base Measurements in Non-OSA, OSA, and sCSF-L Patients
Abbreviations: IAC, internal auditory canal; OSA, obstructive sleep apnea. A, Representative coronal computed
tomographic (CT) image showing skull base (internal auditory canal) height measurement (red line) in a patient without
OSA. B, Representative coronal CT showing skull base height measurement (red line) in a patient with OSA. C, Patients
with OSA had significantly thinner skull base height compared with those without OSA. D, Representative coronal CT
showing an intact tegmen mastoideum. E, Representative coronal CT showing a dehiscent tegmen mastoideum. F, Patients
with OSA had nearly double the incidence of tegmen dehiscence compared with those who did not have OSA (37% vs
20%).
Table.
Patient Demographics and Clinical Data
Characteristic No OSA
(N = 58)
OSA
(N = 56)
Mean Difference (95% CI) Cohen d
Age, mean (SD), y 49.76 (6.14) 50.29 (6.53) 0.53 (−1.83 to 2.88) 0.08
BMI, mean (SD) 38.58 (6.78) 37.39 (8.09) −1.18 (−3.59 to 1.59) 0.16
Sex, No. (%)
Male 10/36 (27.8) 26/36 (72.2)
a
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Female 48/78 (61.5) 30/78 (38.5)
HbA1c, mean, (SD) 6.85 (1.93) 6.95 (1.99) 0.10 (−0.72 to 0.92) 0.05
Calvarial thickness, mean (SD), mm 2.73 (0.67) 2.47 (0.52) −0.26 (−0.49 to −0.04) 0.44
Skull base height, mean, (SD), mm 5.03 (1.40) 4.32 (1.28) −0.71 (−1.23 to −0.19) 0.53
Zygoma thickness, mean, (SD), mm 4.92 (0.87) 4.84 (0.84) −0.07 (−0.39 to 0.24) 0.09
Tegmen dehiscence, % 20 37 17 (0.4 to 32) NA
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared);
HbA1c, hemoglobin A1c; OSA, obstructive sleep apnea.
